首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1562404

2030 年亞太地區腸外營養市場預測 - 區域分析 - 按營養素類型和最終用戶

Asia Pacific Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 95 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2022年亞太腸外營養市場價值為8.6159億美元，預計2030年將達到14.7133億美元；預計2022年至2030年複合年成長率為6.9%。

公司新產品開發推動亞太腸外營養市場

腸外醫療營養市場的公司不斷關注新產品的推出，這有助於他們提高銷售額。以下提到了腸外營養市場的一些值得注意的發展：

2023年，百特韓國推出了Olimel N12E，這是一種富含蛋白質的全腸外營養（TPN）液，適用於重症患者。

2023年，JW Holdings開始透過當地製藥公司AsiaPharma LLC向蒙古大規模出口三腔全腸外營養（TPN）Winuf Central 736/1,085ml。

因此，營養新產品的開發預計將為預測期內的市場成長創造機會。

亞太地區腸外營養市場概況

由於幽門螺旋桿菌感染率不斷上升，中國面臨較高的胃癌負擔。世界衛生組織國際癌症研究機構（IARC）及英國和中國合作機構的一項研究（2021）發現，幽門螺旋桿菌感染在中國很普遍。此外，幽門螺旋桿菌感染是30歲以上成年人62.1%的賁門型胃癌病例和78.5%的非賁門型胃癌病例的主要原因。 IARC的這項研究估計，中國每年約有34萬例因幽門螺旋桿菌感染引起的胃癌病例。根據2020年10月發布的全球疾病負擔資料，胃癌是2019年十大死亡原因之一。萬，粗發病率為33.06。根據同一來源，估計 2020 年男女新發病例數（0-74 歲）為 478,508 例。因此，由於上述因素，預測期內中國腸外營養市場可能會顯著成長。

亞太地區腸外營養市場收入及 2030 年預測（百萬美元）

亞太地區腸外營養市場區隔

亞太腸外營養市場根據營養素類型、最終用戶和國家進行細分。根據營養素類型，亞太地區腸外營養市場分為單劑量胺基酸溶液、腸外脂肪乳、碳水化合物、微量元素以及維生素和礦物質。 2022 年，單劑量胺基酸溶液細分市場佔據最大市場佔有率。

依最終用戶分類，亞太腸外營養市場分為醫院、診所等。 2022 年，醫院細分市場佔據最大市場佔有率。

依國家分類，亞太腸外營養市場分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2022年，中國在亞太腸外營養市場佔有率中佔據主導地位。

ICU Medical Inc、Grifols SA、輝瑞公司、大塚製藥有限公司、百特國際公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd、四川科倫生物製藥有限公司和Vifor Pharma Management AG 是一些領先的公司在亞太腸外營養市場營運的參與者。

China faces a high burden of stomach cancer due to the growing prevalence of H. pylori infection among the people. A study (2021) by the World Health Organization's International Agency for Research on Cancer (IARC) and partner institutions in the UK and China found that H. pylori infection is prevalent in China. Furthermore, H. pylori infection was the prime cause for 62.1% of cardia gastric cancer cases and 78.5% of non-cardia gastric cancer cases among adults over 30 years of age. This study by IARC estimated that ~340,000 cases of gastric cancer due to H. pylori infection occur in China every year. According to Global Burden of Diseases study published in October 2020, stomach cancer was among the top 10 causes of death in 2019. Similarly, according to the latest data from the International Agency for Research on Cancer (IARC), the estimated age-standardized incidence rate for stomach cancer in China is 20.58 per 100,000, and the crude rate is 33.06. As per the same source, the estimated number of new cases (aged 0-74) in 2020 for both sexes was 478,508. Thus, owing to the abovementioned factors, the market for parenteral nutrition is likely to witness remarkable growth in China during the forecast period.

Asia Pacific Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Parenteral Nutrition Market Segmentation

The Asia Pacific parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Asia Pacific parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Asia Pacific parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific parenteral nutrition market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Asia Pacific parenteral nutrition market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 New Product Developments by Companies
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - Asia Pacific Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Parenteral Nutrition Market - Country Analysis

8.1 Asia Pacific
- 8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.1 Overview
    - 8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.5.1 Overview
    - 8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.6.1 Overview
    - 8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Vifor Pharma Management AG
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments
10.10 Aculife Healthcare Pvt Ltd
- 10.10.1 Key Facts
- 10.10.2 Business Description
- 10.10.3 Products and Services
- 10.10.4 Financial Overview
- 10.10.5 SWOT Analysis
- 10.10.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Parenteral Nutrition Market Segmentation
Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)